The DOI matches its Crossref record; 527 of the 529 references it cites were found in a registry or an index.
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Open accessAbstract
Abstract Nanomaterial (NM) delivery to solid tumors has been the focus of intense research for over a decade. Classically, scientists have tried to improve NM delivery by employing passive or active targeting strategies, making use of the so-called enhanced permeability and retention (EPR) effect. This phenomenon is made possible due to the leaky tumor vasculature through which NMs can leave the bloodstream, traverse through the gaps in the endothelial lining of the vessels, and enter the tumor. Recent studies have shown that despite many efforts to employ the EPR effect, this process remains very poor. Furthermore, the role of the EPR effect has been called into question, where it has been suggested that NMs enter the tumor via active mechanisms and not through the endothelial gaps. In this review, we provide a short overview of the EPR and mechanisms to enhance it, after which we focus on alternative delivery strategies that do not solely rely on EPR in itself but can offer interesting pharmacological, physical, and biological solutions for enhanced delivery. We discuss the strengths and shortcomings of these different strategies and suggest combinatorial approaches as the ideal path forward.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumors in humans are poorly diagnosed in the initial stages, which is mainly responsible for the limiting effects of EPR after drug release [102].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Research works printed but not linked: 1
- de Wolf, 2007, Effect of Cationic Carriers on the Pharmacokinetics and Tumor Localization of Nucleic Acids after Intravenous Administration, Int. J. Pharm., 331, 167, 10.1016/j.ijpharm.2006.10.029 · DOI
Cited by
Sorted by citations
Items 501–512 of 512
Li, C., Zhang, Y., Chen, Y., He, L., Shen, X., Sun, W., & Zhang, H. (2026) · Advanced Science · doi:10.1002/advs.77848
Nano Delivery Systems for In Vivo CRISPR/Cas-Based Gene Therapy: From Vectors to Clinical Outcomes
Chen, R., Zhou, H., Wu, Q., & Gong, C. (2026) · ACS Nano · doi:10.1021/acsnano.6c12154
Ban, M., Zhao, S., Liu, Z., & Zhao, L. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101273
Agarwal, J., & Singh, A. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100854
Bakhshandeh, M., & Akhbari, K. (2026) · Materials Today Chemistry · doi:10.1016/j.mtchem.2026.104107
Treatment of different inflammatory thyroid gland diseases utilizing advanced nanocarriers
Abdelbari, M. A., Mosallam, S., & Ahmed, S. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.109048
BindingDB Entry 50021121: Small-molecule inhibitors targeting apoptosis signal-regulated kinase 1.
BindingDB (2025) · UC San Diego · doi:10.7270/q2sx6jtq
Delivery Strategies Targeting Senescent Cells: From Precise Elimination to Functional Remodeling
Liu, Z., Hu, Z., Xia, A., Wang, Q., Li, L., Minglu, Z., Xiang, Y., & Ruan, J. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18111376
Jeelani, P. G. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100849
Louadj, L., Khelifi, S., Benghouzi, P., vandreden, P., Morichon, R., Gligorov, J., Sabbah, M., & Griffete, N. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c01698
Yao, H., Liao, S., Yang, P., Ma, B., Ji, A., Chen, T., Ma, F., Zhang, L., Zou, M., Shi, L., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.183916
Therapeutic potential of glucose oxidase loaded mesoporous silica nanoparticles in ovarian cancer
Peña, A. G. U. (2025) · Repositorio del Tecnológico de Monterrey (Tecnológico de Monterrey)
Metadata
- Authors
- Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J.
- Affiliations
- KU Leuven (BE)
- Corresponding author
- Soenen, Stefaan J.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-01-14
- Volume
- 121
- Issue
- 3
- Pages
- 1746-1803
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- PMC
- PMC7883342
- OpenAlex
- W3118474372
- Cited by
- 506
- References
- 529
- Citations by year
- 2026: 81 · 2025: 91 · 2024: 109 · 2023: 96 · 2022: 94 · 2021: 35
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Chemical Reviews (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Funders
- H2020 European Research Council (757398)
- Fonds Wetenschappelijk Onderzoek (G0B2919N)
- Bijzonder Onderzoeksfonds (3M180306)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- nanoparticle delivery, solid tumors, enhanced permeability and retention effect, tumor vasculature, active targeting, passive targeting, tumor endothelium
- MeSH terms
- Animals, Humans, Neoplasms, Peptides, Drug Delivery Systems, Nanoparticles, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
